May 16 |
Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
May 15 |
ReShape Lifesciences reports Q1 results
|
May 15 |
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
|
May 14 |
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
|
May 9 |
ReShape Lifesciences files to sell 11.7M common shares for holders
|
Apr 3 |
ReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Apr 1 |
ReShape Lifesciences reports FY results
|
Apr 1 |
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
|
Mar 28 |
ReShape Lifesciences gets notice of allowance for additional U.S. patent
|
Mar 28 |
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
|